Method for altering cell fate

Details for Australian Patent Application No. 2002245101 (hide)

Owner Nucleotech, LLC

Inventors Collas, Philippe; Robl, James, M.

Agent Griffith Hack

Pub. Number AU-B-2002245101

PCT Pub. Number WO2002/057415

Priority 10/015,824 10.12.01 US; 60/258,152 22.12.00 US

Filing date 11 December 2001

Wipo publication date 30 July 2002

Acceptance publication date 5 July 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/44 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12Q 1/42 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving phosphatase

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-B-2002245101

5 July 2007 Application Accepted

  Published as AU-B-2002245101

8 November 2007 Standard Patent Sealed

14 August 2008 Assignment Registered

  Nucleotech, LLC The patent has been assigned to Kirin Pharma Kabushiki Kaisha

26 March 2009 Assignment Registered

  Kirin Pharma Kabushiki Kaisha The patent has been assigned to Kyowa Hakko Kirin Co., Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002245102-Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands

2002245100-INSTRUMENTATION AND METHOD FOR INTERVERTEBRAL IMPLANT INSERTION